Novavax Reaches Significant Enrollment Milestone in the Prepare(TM)…

Novavax, Inc. today announced it has reached a significant milestone in the Preparea Phase 3 clinical trial of its respiratory syncytial virus F protein recombinant nanoparticle vaccine for infants via maternal immunization. Enrollment has reached appr...
Continue reading » · Written on: 05-07-18 · No Comments »